Critical analysis of the potential of targeting GPC3 in hepatocellular carcinoma

por Ofuji, Kazuya, Saito, Keigo, Yoshikawa, Toshiaki, Nakatsura, Tetsuya
Publicado 2014

A peptide antigen derived from EGFR T790M is immunogenic in non-small cell lung cancer

por OFUJI, KAZUYA, TADA, YOSHITAKA, YOSHIKAWA, TOSHIAKI, SHIMOMURA, MANAMI, YOSHIMURA, MAYUKO, SAITO, KEIGO, NAKAMOTO, YASUNARI, NAKATSURA, TETSUYA
Publicado 2014

Immunological efficacy of glypican-3 peptide vaccine in patients with advanced hepatocellular carcinoma

por Tsuchiya, Nobuhiro, Yoshikawa, Toshiaki, Fujinami, Norihiro, Saito, Keigo, Mizuno, Shoichi, Sawada, Yu, Endo, Itaru, Nakatsura, Tetsuya
Publicado 2017

Efficacy of immunotherapy targeting the neoantigen derived from epidermal growth factor receptor T790M/C797S mutation in non–small cell lung cancer

por Akazawa, Yu, Saito, Yuki, Yoshikawa, Toshiaki, Saito, Keigo, Nosaka, Kazuto, Shimomura, Manami, Mizuno, Shoichi, Nakamoto, Yasunari, Nakatsura, Tetsuya
Publicado 2020

Circulating cancer‐associated extracellular vesicles as early detection and recurrence biomarkers for pancreatic cancer

por Yoshioka, Yusuke, Shimomura, Manami, Saito, Keigo, Ishii, Hideshi, Doki, Yuichiro, Eguchi, Hidetoshi, Nakatsura, Tetsuya, Itoi, Takao, Kuroda, Masahiko, Mori, Masaki, Ochiya, Takahiro
Publicado 2022

Usefulness of plasma full-length glypican-3 as a predictive marker of hepatocellular carcinoma recurrence after radial surgery

por Miura, Masahiro, Fujinami, Norihiro, Shimizu, Yasuhiro, Mizuno, Shoichi, Saito, Keigo, Suzuki, Toshihiro, Konishi, Masaru, Takahashi, Shinichiro, Gotohda, Naoto, Suto, Kouzou, Yoshida, Tomokazu, Nakatsura, Tetsuya
Publicado 2020

Perioperative plasma glypican-3 level may enable prediction of the risk of recurrence after surgery in patients with stage I hepatocellular carcinoma

por Ofuji, Kazuya, Saito, Keigo, Suzuki, Shiro, Shimomura, Manami, Shirakawa, Hirofumi, Nobuoka, Daisuke, Sawada, Yu, Yoshimura, Mayuko, Tsuchiya, Nobuhiro, Takahashi, Mari, Yoshikawa, Toshiaki, Tada, Yoshitaka, Konishi, Masaru, Takahashi, Shinichiro, Gotohda, Naoto, Nakamoto, Yasunari, Nakatsura, Tetsuya
Publicado 2016

Plasma and tumoral glypican‐3 levels are correlated in patients with hepatitis C virus‐related hepatocellular carcinoma

por Shimizu, Yasuhiro, Mizuno, Shoichi, Fujinami, Norihiro, Suzuki, Toshihiro, Saito, Keigo, Konishi, Masaru, Takahashi, Shinichiro, Gotohda, Naoto, Tada, Toshifumi, Toyoda, Hidenori, Kumada, Takashi, Miura, Masahiro, Suto, Kouzou, Yamaji, Taiki, Matsuda, Takahisa, Endo, Itaru, Nakatsura, Tetsuya
Publicado 2019

Non–clinical efficacy, safety and stable clinical cell processing of induced pluripotent stem cell‐derived anti–glypican‐3 chimeric antigen receptor‐expressing natural killer/innat...

por Ueda, Tatsuki, Kumagai, Ayako, Iriguchi, Shoichi, Yasui, Yutaka, Miyasaka, Tadayo, Nakagoshi, Kengo, Nakane, Kazuki, Saito, Keigo, Takahashi, Mari, Sasaki, Aki, Yoshida, Shinsuke, Takasu, Naoko, Seno, Hiroshi, Uemura, Yasushi, Tamada, Koji, Nakatsura, Tetsuya, Kaneko, Shin
Publicado 2020

Phase I study of glypican-3-derived peptide vaccine therapy for patients with refractory pediatric solid tumors

por Tsuchiya, Nobuhiro, Hosono, Ako, Yoshikawa, Toshiaki, Shoda, Kayoko, Nosaka, Kazuto, Shimomura, Manami, Hara, Junichi, Nitani, Chika, Manabe, Atsushi, Yoshihara, Hiroki, Hosoya, Yosuke, Kaneda, Hide, Kinoshita, Yoshiaki, Kohashi, Kenichi, Yoshimura, Kenichi, Fujinami, Norihiro, Saito, Keigo, Mizuno, Shoichi, Nakatsura, Tetsuya
Publicado 2017